Prescriptions roll out in phases from the 29th, starting at 129,800 won for four weeks. Hanmi reported 9.75% average weight loss at 40 weeks in a phase 3 interim analysis.
Recap by typeshit. Full story at Chosunbiz.
Medicare open enrollment has started, and plan changes include newly negotiated drug prices and lower costs on some medications.
Parker argues patients can spend two weeks fighting for coverage of one GLP-1 without learning another brand might cost them nothing.
Millions of Medicare beneficiaries may want in on the GLP-1 Bridge program, but eligibility rules mean not everyone will qualify.
New generics and steady prices drove the jump in value despite fewer units sold, with Eli Lilly's tirzepatide featured in the breakdown.
No weigh-in this time, just a personal check-in saying the journey is going well so far, plus one thing they've noticed along the way.
A matched cohort study in Inflammatory Bowel Diseases found remission odds nearly six times higher on GLP-1 drugs, and weight loss alone didn't explain it.
Loading…